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Ku is a heterodimeric protein with double-stranded DNA end-binding activity that operates in the process
of nonhomologous end joining. Ku is thought to target the DNA-dependent protein kinase (DNA-PK) complex
to the DNA and, when DNA bound, can interact and activate the DNA-PK catalytic subunit (DNA-PKcs). We
have carried out a 3* deletion analysis of Ku80, the larger subunit of Ku, and shown that the C-terminal 178
amino acid residues are dispensable for DNA end-binding activity but are required for efficient interaction of
Ku with DNA-PKcs. Cells expressing Ku80 proteins that lack the terminal 178 residues have low DNA-PK
activity, are radiation sensitive, and can recombine the signal junctions but not the coding junctions during
V(D)J recombination. These cells have therefore acquired the phenotype of mouse SCID cells despite express-
ing DNA-PKcs protein, suggesting that an interaction between DNA-PKcs and Ku, involving the C-terminal
region of Ku80, is required for DNA double-strand break rejoining and coding but not signal joint formation.
To gain further insight into important domains in Ku80, we report a point mutational change in Ku80 in the
defective xrs-2 cell line. This residue is conserved among species and lies outside of the previously reported
Ku70-Ku80 interaction domain. The mutational change nonetheless abrogates the Ku70-Ku80 interaction and
DNA end-binding activity.
DNA-dependent protein kinase (DNA-PK) is a complex
comprising the heterodimeric Ku protein, which consists of
subunits of 70 and 80 kDa (Ku70 and Ku80), and a large
catalytic subunit, DNA-PKcs (7, 14). Ku has non-sequence-
specific double-stranded DNA (dsDNA) end-binding activity
and, when DNA bound, can interact with DNA-PKcs, enhanc-
ing its kinase activity. DNA-PK functions in a major pathway
for rejoining DNA double-strand breaks (DSBs) in mamma-
lian cells termed nonhomologous end joining (NHEJ) (for
reviews, see references 18 and 23). This process is additionally
used to recombine the site-specific DNA DSBs introduced
during the process of V(D)J recombination. Cell lines defec-
tive in components of DNA-PK are both radiation sensitive,
since the major lethal lesion induced by ionizing radiation is a
DNA DSB, and defective in their ability to carry out V(D)J
recombination (19). Compatible with these cellular studies is
the finding that mice with disrupted components of DNA-PK
exhibit a severe combined immunodeficiency (SCID) pheno-
type and display radiation sensitivity (1, 3, 11, 17, 31, 49).
However, SCID mice, which are defective in DNA-PKcs, have
a less severe V(D)J recombination defect than do Ku-defective
mice and cell lines. Mutants with mutations in Ku are defective
in recombining the two distinct types of junctions that arise
during the process, namely, signal and coding joints. In con-
trast, signal joint formation can proceed largely unimpaired in
mutants defective in DNA-PKcs, although the possibility re-
mains that there is some residual kinase activity in the DNA-
PKcs-defective mutants analyzed to date which is sufficient for
signal joint but not coding-joint formation. This caveat not-
withstanding, it appears that Ku has a function independent of
its role as a component of DNA-PK (for reviews, see refer-
ences 12, 23, and 43).
Neither Ku70 nor Ku80 cDNA has any obvious motifs (28,
37, 48). Ku80 appears to require association with Ku70 for
DNA binding, although Ku70 has been reported to show
Ku80-dependent and -independent DNA binding (45). Ku has
been reported to have ATP-dependent helicase activity, but
both Ku70 and Ku80 lack a helicase domain (44). Ku has been
reported to have ATPase activity following autophosphoryla-
tion, but mutations in putative ATP-binding sites do not impair
the ability of Ku70 or Ku80 to correct defective cell lines (4, 24,
39). Several approaches can provide insight into the identifi-
cation of functional domains within Ku70 and Ku80. Multiple
rodent cell lines defective in Ku80 have been reported, and
identification of the causal mutational changes could poten-
tially provide insight into functionally important domains. To
date, however, such analysis has shown that either the mutants
lack Ku80 expression or the mutations result in large deletions
or truncations due to a changed reading frame (9, 29, 39).
Although important in verifying that Ku80 is the gene defective
in group 5 mutants, these studies have provided little insight
into important functional domains. Other studies have exam-
ined the regions of Ku70 and Ku80 required for heterodimer
formation by using the two-hybrid system and by analysis of in
vitro-expressed cDNA fragments (5, 32, 46). The results show
some discrepancies but, taken together, define a minimal do-
main of 28 amino acids from the central region of Ku80 (res-
idues 449 to 477) that is required for Ku70-Ku80 interaction.
Additionally, amino acid residues 334 to 449 of Ku80 appear to
be required for DNA end-binding activity (46). Two studies
have reported aberrant Ku80 proteins in human cell extracts
that apparently lack the C terminus and have DNA end-bind-
ing but not DNA-PK activity, suggesting that the C-terminal
region of Ku80 might be involved in interacting with DNA-
PKcs (16, 30). Ku has been widely recognized as the DNA-
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binding component of DNA-PK that activates the catalytic
subunit (DNA-PKcs) when DNA bound. The lack of DNA-PK
activity in both Ku-defective and DNA-PKcs-defective cell
lines has substantiated these in vitro findings (2, 10, 35). Re-
cent studies, however, have challenged this view, showing that
DNA-PKcs can bind to linear DNA fragments and function as
a protein kinase in the absence of Ku and that Ku merely
stimulates DNA-PK activity up to eightfold (47). Hammarsten
and Chu (15) have also reported similar findings and con-
cluded that Ku stabilizes the recruitment of DNA-PKcs to
DNA ends and that a cooperative interaction between Ku,
DNA-PKcs, and DNA efficiently activates the DNA-PKcs ac-
tivity.
In this study, we have used two approaches to study Ku80
function. First, to gain further insight into the role of the Ku80
C terminus, we have examined C-terminally truncated Ku80
proteins for their ability to interact with Ku70, to bind dsDNA
ends, and to interact with and activate DNA-PKcs. We exam-
ined the activity of the proteins generated following cotrans-
lation with full-length Ku70 and, to gain insight into the sig-
nificance of these in vitro findings, introduced truncated Ku80
cDNAs into Ku80-defective xrs-6 cells. Our results suggest that
the C-terminal region of Ku80 is dispensable for interaction
with Ku70 and for DNA end binding but is required for opti-
mal DNA-PK activity. Cells lacking this region of Ku80 acquire
the phenotype of cells defective in DNA-PKcs and are able to
rejoin signal but not coding junctions during V(D)J recombi-
nation. We also report the identification of a point mutational
change in Ku80-defective xrs-2 cells. This is the first Ku80
mutant harboring a point mutational change, and it identifies a
site outside of the previously described Ku70-Ku80 minimal
interaction domain that is nonetheless required for hetero-
dimer formation.
MATERIALS AND METHODS
Cell culture, DNA transfections, and protoplast fusions. The xrs cell lines were
derived from the CHO-K1 cell line on the basis of their sensitivity to ionizing
radiation (21). Cells were cultured in minimal essential medium (Gibco) sup-
plemented with nonessential amino acids, penicillin, streptomycin, glutamine,
and 10% fetal calf serum as described previously (21). Transfection was carried
out by the Polybrene transfection method as described previously (22). Trans-
fectants were selected by using 600 mg of G418 per ml alone or with 50 mg of
zeocin per ml and subsequently maintained in 300 mg of G418 per ml alone or
with 50 mg of zeocin per ml. Yeast artificial chromosomes (YACs) were trans-
ferred to rodent cells by the protoplast fusion protocol described previously (2).
Isolation and preliminary characterization of the DNA-PKcs YAC have been
described previously (2, 36). Experiments to assess survival in response to ion-
izing radiation were as described previously (21). V(D)J recombination assays
were as described previously (40, 41).
Analysis of DNA transfectants. Between 6 and 15 clones were picked per
transfection and analyzed by PCR for the presence of the construct. PCR was
carried out in 25 ml containing 2.5 ml of 103 PCR buffer (100 mM Tris [pH 9],
500 mM KCl, 15 mM MgCl2, 0.1% gelatin, 1% Triton X-100), 1.25 ml of each
deoxynucleoside triphosphate (2.5 mM), 20 ng of each primer, and 0.25 U of Taq
polymerase (HT Biotechnology Ltd. and Advanced Biotechnologies). Clones
transfected with Chinese hamster (CH) Ku80 cDNA were analyzed with primers
AP34 and AP35 (39) or primers AP34 and SP6 (a vector-specific primer for SP6
promoter). Human (Hs) Ku80 cDNA was detected with primers Ku80 PN
(59GTC GGG GAA TAA GGC AGC TGT39) (positions 9 to 29) and Ku80 PP
(59ACT TGG TTT GTC TTT GGG GGC39) (positions 2136 to 2116) for
full-length Ku80 or primers C (39) and D (59TTT GTC TTT GGG GGC CAG
AAA CTT39) (positions 2130 to 2107) for the 39 half of the cDNA. At least two
PCR-positive clones from each transfection were analyzed further.
Construction of Ku80 constructs. Full-length CH Ku80 cDNA was cloned into
pcDNA3 as described previously (39). Full-length Hs Ku80 cDNA was PCR
amplified with primers containing BamHI sites and cloned into the BamHI site
of pcDNA3.1/HisC (Invitrogen). The deletion constructs were generated as
described below. For D560, a termination codon at residue 560 followed by a
XhoI site was created by site-directed mutagenesis. The C-terminal portion was
then removed by XhoI digestion and religation. The remaining deletion con-
structs were generated by the introduction of two adjacent termination codons by
site-directed mutagenesis at the residues indicated. The xrs-2 mutation was
introduced into Ku80 cDNA by site-directed mutagenesis. All site-directed mu-
tagenesis was carried out by the method of Kunkel et al. (25).
In vitro transcription and translation. Full-length Hs Ku70 was subcloned into
the pcDNA3 vector. A 0.5-mg portion of each Ku80 construct (or pcDNA3 vector
alone) was coexpressed with 0.5 mg of pcDNA3 Hs Ku70 in a 25-ml transcription-
translation system as specified by the manufacturer (Promega TNT T7 quick-
coupled transcription/translation system). A 2.5-ml volume of each reaction mix-
ture was used for Western blot analysis. Hs Ku80 proteins were detected with
anti-Xpress antibody (Invitrogen) following 1:1,000 dilution in 1% milk. Ku70
was detected with Ku70-6 antibody diluted 1:5,000 in 5% milk. Coimmunopre-
cipitation was examined with 10 ml of TNT reaction product following overnight
incubation at 4°C with Ku70-6. The antigen-antibody complexes were isolated
following incubation with protein A-Sepharose and extensive washing. Immuno-
precipitation of Ku70 was verified with anti-Ku70 antibody, N3H10, diluted
1:5,000 in 2% milk. Coimmunoprecipitation of Ku80 was detected with anti-
Xpress antibody.
End-binding and DNA-PK assays. DNA end-binding assays were carried out
essentially as described previously (14, 41). In brief, extracts were prepared by a
modification of the method of Scholer et al. (38) and were incubated with
g-32P-labelled ds oligonucleotide M1/M2 at room temperature for 30 min, and
DNA-protein complexes were resolved on 4% polyacrylamide gels containing
5% glycerol. The modified DNA-PK assay in which the phosphorylated product
is separated by polyacrylamide gel electrophoresis (PAGE) was carried out
essentially as previously described (36).
Immunoblotting. Whole-cell extracts (120 mg for hamster cell extracts and 60
mg for human cell extracts) were boiled in sodium dodecyl sulfate (SDS)-PAGE
loading buffer, and separated by SDS-PAGE (8% polyacrylamide). Proteins were
transferred to nitrocellulose by using a wet-blotting apparatus and blocked for
1 h to overnight at 4°C with 5% skim milk solution and 0.05% Tween. The
primary antibodies were Ku80-4 and Ku70-6, which were raised against baculo-
virus-expressed Hs Ku80 and Ku70 proteins, respectively (Serotech). For the
detection of hamster proteins, the Ku80-4 or Ku70-6 primary antibody was
diluted 1:5,000 and 1:2,500, respectively, in 2% milk solution and incubated for
2 to 3 h at room temperature, the mixture was washed extensively in milk
solution, and anti-rabbit immunoglobulin antibody (diluted 1:2,500) was added
for 1 hr at room temperature. The filter was rewashed and developed with an
ECL kit (Amersham). For the detection of human proteins, the Ku80-4 antibody
was diluted 1:1,000 in 5% milk and the monoclonal anti-Ku70 antibody, N3H10,
was diluted 1:5,000 in 2% milk.
cDNA synthesis and sequencing. Poly(A)1 RNA was extracted from 5 3 107
cells with a Quickprep Micro mRNA Purification kit (Pharmacia Ltd.). Reverse
transcription-PCR (RT-PCR) and sequencing of the Ku80 gene from xrs-2 cells
were carried out with the primers and method described previously (39). To
verify the sequence of mouse Ku80 cDNA, mouse Ku80 cDNA was amplified by
RT-PCR with C57BL/6 testis RNA. Primers AP7 (59GGA ACA AAT GAA
ATA TAA AT39) and D (39TTT GTC TTT GGG AGC CAG GAA CTT39) were
used to amplify the relevant region. The products were cloned into a T vector and
sequenced by standard procedures.
RESULTS
Analysis of Ku80 3* deletion constructs. To investigate the
function of the C-terminal region of Ku80, a series of Ku80
cDNAs having 39 deletions of different sizes were generated
(Table 1). Some of the deletions were derived with CH Ku80
cDNA in the mammalian expression vector pcDNA3. Subse-
quently, additional deletions were generated with Hs Ku80
cDNA in a pcDNA3 vector containing an Xpress epitope tag.
The former has the advantage that the full-length CH Ku80
cDNA fully corrects the Ku80-defective xrs-6 cells but has the
disadvantage that the Hs Ku80 antibodies that cross-react with
CH Ku80 do not recognize the C-terminally truncated proteins
(the proteins show 80.3% homology at the amino acid level).
The use of Hs cDNA constructs therefore enabled a wider
range of antibodies as well as the anti-Xpress antibody to be
used.
(i) Analysis with in vitro-expressed proteins. First, the trun-
cated Ku80 proteins of human origin were examined for their
ability to interact with Ku70 following their coexpression with
full-length Hs Ku70 cDNA in an in vitro translation system
with rabbit reticulocyte lysates. The expression of Ku80 protein
was assessed by Western blotting with anti-Xpress antibody
(Fig. 1A). To examine the Ku70-Ku80 interaction, Ku70 pro-
tein was immunoprecipitated with anti-Ku70 antibodies and
coimmunoprecipitation of Ku80 was determined with anti-
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Xpress antibodies (Fig. 1B). In the absence of Ku80 cDNA in
the translation system, no anti-Xpress cross-reacting protein
was detectable (Fig. 1A, lane pcDNA3 vector). Ku80 truncated
proteins lacking up to 178 amino acid residues interacted as
efficiently with Ku70 as did the full-length protein, while Hs
Ku80D510 (where D510 denotes deletion of C-terminal resi-
dues 510 to 732) displayed slightly reduced Ku70 interaction,
as determined by the amount of Ku80 coimmunoprecipitated
relative to that expressed (compare Fig. 1B with Fig. 1A). The
same results were obtained by examining the ability of Ku80
antibodies to coimmunoprecipitate Ku70 protein (data not
shown). The smaller size of the Ku80 protein verifies that the
site-directed mutations generated yield the anticipated trun-
cated proteins. Next, we determined whether the in vitro-trans-
lated proteins had DNA end-binding activity by examining
them in an electrophoretic mobility shift assay (EMSA) (Table
1; Fig. 1C). A low background level of DNA end-binding
activity was obtained in the absence of Ku70 and Ku80 cDNA
or in the presence of either cDNA alone, probably due to Ku
homologues present in the reticulocyte lysates (Fig. 1C). Full-
length Hs Ku80 and deletions up to Hs Ku80D554 had similar
DNA end-binding activity, while the protein with the larger
truncation (Hs Ku80D510) gave no end-binding activity above
background (Fig. 1C). Surprisingly, Hs Ku80D510 showed sig-
nificant Ku70-Ku80 interaction but no residual DNA end-bind-
ing activity. However, EMSA with Hs Ku80D510 gave smaller,
smeared band shift products (Fig. 1C), possibly suggesting an
unstable Ku complex dissociating during the electrophoresis.
Results consistent with this were also obtained with the trun-
cated proteins of hamster origin, although the Ku70-Ku80 in-
teraction could not be assessed due to the lack of cross-react-
ing Ku80 antibody (Table 1). CH Ku80D531 had impaired
DNA end-binding activity and also showed a smaller, smeared
band shift product like that observed with Hs Ku80D510. CH
Ku80D474 had no end-binding activity above background. Col-
lectively, these results show that the C-terminal 178 amino acid
residues of Ku80 are dispensable for both Ku70-Ku80 interac-
tion and DNA end-binding activity. Loss of additional se-
quences to residue 510 impinges upon both heterodimer for-
mation and DNA end-binding activity.
(ii) Analysis following transfection into xrs-6 cells. To gain
insight into the function of the Ku80 C-terminal region in vivo,
a subset of the 39-deleted cDNAs were introduced into Ku80-
defective xrs-6 cells by DNA transfection (Table 1). xrs-6 cells
have no residual Ku-dependent DNA end-binding or DNA-PK
activity due to the presence of an inactivating missplicing mu-
tation close to the N terminus of the Ku80 open reading frame
(29, 39). Individual stable transfectants were selected with the
neomycin marker present in pcDNA3 and screened by PCR
with primers that amplify the Ku80 cDNA construct used. A
minimum of two transfectants from each transfection were
analyzed for the presence of Ku70 and Ku80 protein by West-
ern blot analysis, for DNA end binding and DNA-PK activity.
The clones derived from these transfections are named to
reflect the construct used: e.g., XCH80D560 represents a stable
transformed clone of xrs-6 with hamster Ku80D560. Normal
levels of truncated Ku80 protein are expressed in XHs80D554
cells (Fig. 2A). Expression of Ku80 protein in clones derived
with the other constructs could not be assessed since the trun-
cated CH proteins do not cross-react with the anti-Ku80 anti-
bodies. xrs-6 cells, as well as Ku80 knockout cell lines, have
little or no Ku70 protein, demonstrating that Ku70 is unstable
in the absence of Ku80 (6, 31, 39, 41). The faint residual signal
seen in Western blot analysis of xrs-6 cells with anti-Ku70
antibodies could be due to residual Ku70 protein in the ab-
sence of Ku80 or to some other cross-reacting protein (Fig.
2A). The recovery of Ku70 protein in the transfected clones
assessed by Western blot analysis was therefore used to mon-
itor the interaction of Ku80 with Ku70 in vivo. Ku70 pro-
tein was clearly stabilized in XCH80D560 and XHs80D554
cells (Fig. 2A). Thus, it is likely that Ku80 is expressed in
XCH80D560 clones, although it is not seen in the Western
blots due to lack of cross-reactivity of the Ku80 antibodies.
When the constructs with larger deletions were used, only low
residual Ku70 protein levels were seen, comparable to that
observed in xrs-6 cells (Fig. 2A). Taken together, these results
suggest that the Hs80D554 and CH80D560 truncated proteins
are stably expressed and interact efficiently with Ku70 in vivo.
The lack of Ku70 protein in clones bearing the larger deletions
probably reflects the reduced ability of the truncated Ku80
proteins to interact with Ku70, although we have not verified
that Ku80 is expressed in these clones. The DNA end-binding
activity of the clones is closely correlated with the stabilization
of Ku70 protein (Fig. 2B). Thus, XHs80D554 and XCH80D560
had wild-type levels of DNA end-binding activity, while the two
larger deletions resulted in loss of such activity.
To measure DNA-PK activity, DNA-binding proteins were
first microfractionated from whole-cell extracts by using DNA-
cellulose beads and then assayed for kinase activity with a
p53-derived peptide as substrate (10). The phosphorylated
TABLE 1. Analysis of Ku80 C-terminal deletion constructs
Constructe Species
In vitro translation
analysis Transfection into xrs-6 cells Transfection into xrs-6/YAC fusion hybrids
Subunit
interaction EMSA
Ku70
(WB)b
Ku80
(WB) EMSA
Kinase
activity IR
b Ku70
(WB)
Ku80
(WB) EMSA
Kinase
activity IR
Ku80 Hamster 11 11 11 11 11 1 R 11 11 11 111 R
Ku80 Human 11 11 11 11 11 1 Partial R 11 11 11 111 Partial R
D560–732 Hamster NDa,b 11 11 NDa 11 '30%c Partial R ND NDa 11 40%c R
D554–732 Human 11 11 11 11 11 ,5%d S ND 11 11 23%d S
D531–732 Hamster NDa 6 2 NDa 2 ,0.1% S ND ND ND ND ND
D510–732 Human 1 2 ND ND ND ND ND ND ND ND ND ND
D474–732 Hamster NDa 2 2 NDa 2 ,0.1% S ND ND ND ND ND
a CH-derived Ku80 truncated proteins were not recognized by the anti-Ku80 antibody, 80-4, and therefore could not be analyzed by Western blot analysis.
b WB, Western blot; ND, not done; S, as sensitive to ionizing radiation (IR) as xrs-6 cells; R, as resistant to ionizing radiation as CHO-K1 cells.
c Expressed relative to the activity seen in xrs-6 cells complemented with CH Ku80 cDNA.
d Expressed relative to the activity seen in xrs-6 cells complemented with Hs Ku80 cDNA.
e Constructs C-terminally deleted at positions 622, 591, and 563 were also analyzed in the in vitro transcription system. All the resulting truncated proteins were
proficient in subunit interaction and in DNA end-binding.
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product was separated by polyacrylamide gel electrophoresis
and quantified by scanning. This procedure considerably en-
hanced the sensitivity of the assay by separating DNA-PK
independent, nonspecific phosphorylated products from the
p53 peptide (36). Only clones with DNA end-binding activity
were examined for kinase activity. Phosphorylation of the p53
peptide with extracts of xrs-6 cells was not significantly above
background (the signal obtained in the absence of p53 pep-
tide). Clones expressing full-length CH Ku80 have levels of
activity comparable to that obtained with CHO-K1 cells, which
is three- to fivefold above background (data not shown). The
activity obtained with clones expressing Hs Ku80 cDNA was
approximately half of that obtained with wild-type cells (data
not shown). XHs80D554 and XCH80D560 clones reproducibly
had decreased DNA-PK activity compared to that of clones
expressing the corresponding full-length Ku80 protein, which
by scanning was estimated to be 4% (XHs80D554) and 28%
(XCH80D560) of the signal obtained with clones expressing
full-length Ku80 of the same species (data not shown). How-
ever, although the decrease in kinase activity was reproducible,
the quantitative estimation of the decrease is highly inaccurate
due to lack of sensitivity of the kinase assay in the rodent cells.
These limitations notwithstanding, these results raise the pos-
sibility that clones with normal DNA end-binding activity have
reduced kinase activity and suggest that the C-terminal region
of Ku80 is required for kinase activation.
The ability of the Ku80 deletion constructs to complement
the radiation sensitivity of xrs-6 cells was also examined (Fig.
2C). XCH80D560 clones that retained approximately one-third
of the kinase activity found in control cells had elevated g-ray
survival compared with xrs-6 cells or cells transfected with an
empty vector but less than that observed with wild-type CH
Ku80 cDNA or parental cells. In contrast, the larger deletions
were unable to complement the radiation sensitivity of xrs-6
cells. Clones expressing Hs Ku80D554 cDNA resemble cell
lines defective in DNA-PKcs (e.g., the mouse SCID cell line) in
having DNA end-binding activity but lacking DNA-PK activity
(2, 13). DNA-PKcs-defective cell lines (V-3, irs20, and the
mouse SCID line) differ from Ku80-defective lines in the na-
ture of their V(D)J recombination defect (26, 27, 34, 40, 42).
Ku80-defective mutants have major defects in both signal joint
and coding-joint formation, whereas the DNA-PKcs-defective
lines can rejoin signal sequences with only a slightly impaired
frequency. Additionally, while signal junctions are normally
accurate in control cells, those formed in DNA-PKcs-defective
lines have an elevated frequency of deletions. We therefore
examined the ability of the XHs80D554 cells to carry out signal
joint and coding-joint formation. XHs80D554 cells significantly
recovered the frequency of signal joint formation to 50% of the
level seen in clones expressing full-length Hs Ku80, although
the defect in coding-joint formation remained (Table 2). The
accuracy of signal joint formation also increased, although
some junctions had deletions. Therefore, cells expressing this
Ku80 deletion construct have the V(D)J recombination phe-
notype of cells lacking DNA-PKcs, even though they do ex-
press DNA-PKcs protein. XCH80D560 clones showed consid-
erable recovery of coding-joint formation, suggesting that their
higher level of DNA-PK activity is sufficient to carry out coding
joint formation effectively. This is consistent with their ele-
vated survival (Fig. 2C).
Overexpression of DNA-PKcs in xrs-6 cells. Rodent cells
have approximately 50-fold-lower levels of DNA-PK proteins
than do human cells. While human cells have high levels of
DNA-PK activity, we routinely observed levels of DNA-PK
activity in parental CHO-K1 cells only three- to fivefold above
background. This made it difficult to monitor accurately the
decrease in kinase activity in transfectants expressing the Ku80
deletion constructs. Previously, we have shown that rodent
cells harboring a YAC expressing Hs DNA-PKcs express hu-
man levels of the protein and have high DNA-PK activity
compared with wild-type rodent cells (2, 36). This suggests that
DNA-PKcs is rate limiting for DNA-PK activity and provided
a tool to overexpress DNA-PKcs and enhance the sensitivity of
the DNA-PK assay in the rodent cells. First, we examined the
effect of overexpression of DNA-PKcs in xrs-6 cells by intro-
ducing YACs encoding Hs DNA-PKcs into CHO-K1 and xrs-6
FIG. 1. Analysis of in vitro-expressed C-terminally truncated Ku80 proteins.
(A) Western blot analysis of in vitro-expressed Ku80 proteins. A 2.5-ml volume
of reticulocyte lysate, following coexpression of full-length Ku70 and pcDNA3
vector alone, full-length Hs Ku80 cDNA, and truncated Ku80 cDNAs as indi-
cated, was used for Western blot analysis with the anti-Xpress antibody to detect
Ku80 protein. (B) Coimmunoprecipitation of Ku80 and Ku70. A 10-ml volume of
coexpressed Ku70/vector control (“pcDVA3 vector only” lane) or Ku70-Ku80
proteins as indicated were immunoprecipitated with the anti-Ku70 antibody,
Ku70-6, and coimmunoprecipitation of Ku80 was examined with the anti-Xpress
antibody. (C) DNA end-binding activity of in vitro-expressed proteins. Expressed
proteins (2.5 ml) as indicated were used in an EMSA. The band labeled “Ku
band” represents Ku-dependent dsDNA end-binding activity. The aberrant band
represents a smeared product routinely observed when construct Hs Ku80D510
is used (see text for details). The mobility of the band shift products generally
reflected the size of the Ku80 product, with the exception of Hs KuD563, which
may be due to altered conformation of the heterodimer. Autoradiographic im-
ages were scanned on an AGFA StudioStar scanner with FotoLook32 software.
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cells by protoplast fusion. As previously reported, fusion clones
(designated CHO-K1Y or xrs-6Y) derived from both CHO-K1
and xrs-6 expressed the higher levels of DNA-PKcs expected
(36) (Fig. 3A). Cell extracts from the fusion clones were next
examined for DNA-PK activity. While CHO-K1Y clones had
approximately 20- to 30-fold-higher levels of activity than con-
trol CHO-K1 cells, the DNA-PK activity in xrs-6 cells express-
ing DNA-PKcs YACs (xrs-6Y) was only marginally increased
(Fig. 3B). It is also notable that xrs-6Y clones expressing full-
length CH Ku80 protein had DNA-PK activity 50- to 100-fold
above that present in xrs-6Y clones, demonstrating the signif-
icant increase in kinase activity when Ku is present (Fig. 3B).
The overexpression of DNA-PKcs in these clones did not affect
the phenotype of either CHO-K1 or xrs-6 cells and did not
affect their level of radiosensitivity (36). The high levels of
DNA-PKcs in these fusion clones, however, allowed us to ex-
amine the effect of Ku on the ability of DNA-PKcs to bind to
DNA. To assess DNA-PKcs/DNA binding, half the microfrac-
tionated DNA-binding proteins obtained during the DNA-PK
assay were boiled to remove the bound proteins and examined
for the presence of DNA-PKcs by Western blotting (Fig. 3A,
Pd). High levels of DNA-PKcs were recovered from extracts of
FIG. 2. Analysis of xrs-6 transfectants expressing C-terminally truncated Ku80 proteins. (A) Western blot analysis of xrs-6 transfectants with anti-Ku70 and
anti-Ku80 antibodies. Protein (120 mg) in whole-cell extracts from cells expressing CH Ku80 and protein (60 mg) in whole-cell extract from cells expressing Hs Ku80
were subjected to Western blotting with antibodies Ku80-4 and Ku70-6. The lack of Ku80 protein in XCH80D560, XCH80D531, and XCH80D474 is due to the inability
of the Ku antibody to recognize the truncated CH proteins. The presence of Ku70 protein with XCH80D560 indicates heterodimer formation and hence Ku80
expression. (B) EMSA of extracts from xrs-6 transfectants. Whole-cell extracts (30 mg) from the xrs-6 transfectants indicated were subjected to EMSA. Cold circular
DNA was not added as competitor in these assays, resulting in the presence of a heavy band of non-Ku-specific DNA binding. The Ku-specific bands are labeled. The
human samples were analyzed on a different gel from the hamster samples, and so a direct comparison of the mobilities cannot be made. However, the band shift
involving Hs Ku80 routinely has a lower mobility than that involving CH Ku80, as also seen in Fig. 4 and as observed previously (41). WT, wild type. (C) Survival of
transfectants following exposure to ionizing radiation. Cells were exposed to the indicated dose of ionizing radiation, and survival was estimated after 7 days of
incubation. Autoradiographic images were scanned on an AGFA StudioStar scanner with FotoLook32 software.
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CHO-K1Y cells in this pull-down assay, and lower but mea-
surable levels were obtained from control CHO-K1 cells ex-
pressing only endogenous DNA-PKcs (Fig. 3A). No detectable
DNA-PKcs was recovered from xrs-6 cells in this pull-down
assay, even though DNA-PKcs was present in the whole-cell
extract (Fig. 3A), but low levels have been recovered in other
experiments (data not shown). The level of DNA-PKcs recov-
ered from the pull-down fraction by using extracts from xrs-6Y
cells was variable but was always markedly lower than that
recovered from CHO-K1Y extracts (Fig. 3B). However, de-
spite the recovery of DNA-PKcs from extracts of xrs-6Y cells,
only low DNA-PK activity was observed (Fig. 3B). The re-
sponse to radiation and the V(D)J recombination phenotypes
of xrs-6 and CHO-K1 cells were unaffected by the presence of
the DNA-PKcs YAC (for data on the survival of xrs-6 cells, see
Fig. 4C). Taken together, these results show that Ku signifi-
cantly enhances the ability of DNA-PKcs to bind to DNA and
to function as a DNA-dependent protein kinase.
Transfection of Ku80 C-terminal deletion constructs into
DNA-PKcs-overexpressing xrs-6 cells. The low level of DNA-
PKcs activity in rodent cells limited our ability to assess the
magnitude of the defect in DNA-PKcs interaction resulting
from the C-terminal truncations of Ku80. We were also unable
to assess efficiently whether the Ku80 deletion constructs im-
paired the ability of DNA-PKcs to interact with DNA. We
therefore introduced the two most informative 39 deletion con-
structs (Hs Ku80D554 and CH Ku80D560) and full-length
Hs or CH Ku80 cDNA into xrs-6Y cells, yielding transfor-
mants designated XYHs80D554, XYCH80D560, XYHs80, and
XYCH80, respectively. First, the constructs were subcloned
into a pZeoSV vector, since the YACs encoded the neomycin
selectable marker, and subsequently they were transferred to
xrs-6Y cells by DNA transfection and selection for resistance to
zeocin. All the clones expressed a truncated Ku80 protein, and
Ku70 protein was stabilized, indicating efficient Ku70-Ku80
interaction (Fig. 4A; not visible for CH80D560 due to the in-
ability of Ku80 antibody to cross-react with rodent protein).
Cell extracts from these clones also had DNA end-binding
FIG. 3. Interaction of DNA-PKcs with DNA and DNA-PK activity in the absence of Ku. (A) Recovery of DNA-PKcs from DNA cellulose beads. (Top) Protein
(50 mg) from whole-cell extracts (WCE) of CHO-K1 and xrs-6 cells either expressing DNA-PKcs YACs (lanes CHO-K1Y and xrs6Y) or not carrying DNA-PKcs YACs
(lanes CHO-K1 and xrs6) was subjected to Western blotting with the monoclonal anti-DNA-PKcs antibody, 18-2. (Bottom) DNA-binding proteins from 150 or 300 mg
of protein from whole-cell extracts were microfractionated with DNA-cellulose beads and then analyzed for DNA-PKcs by Western blotting. Pd represents extracts
microfractionated for DNA-binding proteins by the pull-down assay with DNA-cellulose beads. The lighter upper band is DNA-PKcs, and the heavy lower band is a
220-kDa protein routinely seen when anti-DNA-PKcs antibodies are used. Autoradiographic images were scanned on an AGFA StudioStar scanner with FotoLook32
software. (B) Kinase activity. DNA-PK activity was assayed following a pull-down assay of DNA-binding proteins with DNA-cellulose beads. The substrate is a
p53-derived peptide, which was analyzed for phosphorylation by PAGE. The intensity of the p53 band was assessed by phosphorimager scanning. The activity is
expressed relative to that obtained with xrs-6/YAC cells complemented with full-length CH Ku80 cDNA. No activity above background was obtained with xrs-6 cells.
The activity obtained with xrs-6/YAC fusion hybrids was low but reproducibly above background levels. CHOK1-Y and xrs-6Y represent CHO-K1 and xrs-6 cells
expressing the YAC encoding DNA-PKcs, respectively; XYCH80, XYCH80D560, XYHs80, and XYHs80D554 are xrs-6/YAC fusion hybrids expressing CH Ku80, CH
Ku80D560, Hs Ku80, and Hs Ku80D554 constructs, respectively.
TABLE 2. Analysis of signal joint and coding-joint formation by
transient V(D)J recombination assaya
Cell line
PJH200 (signal joints) PJH290 (coding joints)
No. Ampr/
no. Chlr
%
recombinedb
Fidelity
(%)
No. Ampr/
no. Chlr
%
recombinedb
XHs80 220/7,650 2.9 100 292/17,400 1.7
XHs80D554 27/1,770 1.5 93 4/5,220 0.07
XCH80 120/3,275 3.2 100 116/3,670 3.2
XCHD560 471/13,950 3.4 100 148/14,100 1.1
xrs-6 20/15,000 0.15 0 2/3,150 0.06
a Mouse SCID and V-3 cells have approximately a 50-fold defect in coding-
joint formation and a 2-fold defect in signal joint formation. SCID and V-3 cells
rejoin signal joints with 60 to 80% fidelity (34, 40).
b The percent correct RS joints screened by ApaLI digestion of the PCR
product by using the recombination substrate pJH200. The results represent the
mean of at least three independent transfection experiments.
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activity with the predicted altered mobility (Fig. 4B). xrs-6Y
cells expressing full-length CH Ku80 protein had DNA-PK
activity 20- to 50-fold above that obtained with CHO-K1
cell extracts and similar to that found in CHO-K1Y cells
(Fig. 3B) and human cells (36). In contrast, DNA-PK ac-
tivity was decreased in clones expressing the 39 deletion
constructs, although some residual activity was detectable,
which was lower with the larger deletion (Fig. 3B; Table 1).
Although XYHs80D554 has markedly lower kinase activ-
ity than XYCH80D560 did, this is more likely to be due to
the different species origin of the proteins than to a specific
functional significance of the extra 6 amino acids deleted.
An additional deletion construct (Hs Ku80D543) was intro-
duced into xrs-6Y cells, and the transfectants derived had an
almost identical phenotype to XYHs80D554 cells, with 6%
of the parental kinase activity (data not shown). Thus, de-
letion of an additional 11 amino acid residues does not
decrease the residual kinase activity. These results substan-
FIG. 4. Analysis of extracts of xrs-6Y clones. (A) Protein (50 mg) from whole-cell extracts was separated by SDS-PAGE through 8% polyacrylamide gels and
subjected to Western blotting with the Ku70 and Ku80 antibodies, N3H10 and Ku80-4. (B) EMSA analysis. Whole-cell extracts (30 mg) from the xrs-6Y clones indicated
were subjected to EMSA. (C) Survival of xrs-6Y clones in response to ionizing radiation. (D) Recovery of DNA-PKcs from DNA-cellulose beads. (Top) Protein (15
mg) from whole-cell extracts (WCE) of CHO-K1Y cells, xrs-6Y cells expressing full-length Hs Ku80, xrs-6Y cells expressing CH Ku80D554, and xrs-6Y cells was
subjected to Western blotting with anti-DNA-PKcs antibody, 18-2. (Bottom) DNA-binding proteins derived from 150 mg of protein from the same whole-cell extracts
were first microfractionated with DNA-cellulose beads and then analyzed for DNA-PKcs with antibody 18-2. Pd represents extracts microfractionated for DNA-binding
proteins by pull-down assays with DNA-cellulose beads. Autoradiographic images were scanned on an AGFA StudioStar scanner with FotoLook32 software.
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tiated those obtained with the xrs-6 parental cells and veri-
fied that the C-terminal region of Ku is required for optimal
DNA-PK activity. To assess whether DNA-PKcs can interact
with DNA in the presence of the Ku80 truncated proteins,
we used Western blotting to examine the microfractionated
DNA-bound proteins obtained in XYHs80D554 cells for
DNA-PKcs levels. The level of DNA-PKcs protein recov-
ered from extracts of XYHs80D554 cells was markedly lower
than that recovered from xrs-6Y cells expressing full-length
Ku80 protein and similar to that obtained with xrs-6Y cells
(Fig. 4D). These results show that the major impact of the
C-terminal Ku80 deletions is to impair DNA-PKcs binding
to DNA. Decreased but measurable kinase activity was de-
tected with these extracts, however. The survival of these
clones after exposure to g-irradiation was also examined.
While XCH80D560 cells were partially complemented for
radiation sensitivity (Fig. 2C), XYCH80D560 cells had a
level of resistance close to that of parental CHO-K1 cells
(Fig. 4C). In contrast, expression of the Hs Ku80D554 pro-
tein resulted in only minor complementation of the radia-
tion sensitivity of the xrs-6Y cells.
Identification of a point mutation in Ku80-deficient xrs-2
cells. xrs-2 is a Ku80-defective mutant that displays slightly less
radiation sensitivity compared to other xrs mutants (21). Like
other xrs mutants, xrs-2 lacks Ku70 and Ku80 proteins, detect-
able dsDNA end binding, and DNA-PK activity, but the Ku80
transcript levels are normal (data not shown). Sequence anal-
ysis of Ku80 cDNA from xrs-2 cells by RT-PCR identified a
C-to-T base change at position 1229 that results in the substi-
tution of a leucine for a proline at residue 410. Although a
proline at this position is conserved between human, hamster,
Caenorhabditis elegans, and Saccharomyces cerevisiae Ku80
proteins, the GenBank sequence (U68181) for mouse Ku80
showed a leucine at this position. We sequenced this region
from mouse Ku80 cDNA and found, contrary to the published
sequence, a proline at residue 410. This amino acid residue is
therefore conserved between species, enhancing the likelihood
that the mutational change identified in xrs-2 at this residue
represents the causal inactivating mutation.
To verify the significance of this mutational change, we gen-
erated the mutation in CH Ku80 cDNA by site-directed mu-
tagenesis and coexpressed the mutated cDNA (designated
xrs-2 cDNA) with full-length Ku70 in the reticulocyte lysate in
vitro translation system. The xrs-2 Ku80 protein generated
cross-reacted with anti-Ku80 antibodies but was unable to co-
immunoprecipitate Ku70 (data not shown), and the coex-
pressed proteins lacked DNA end-binding activity (Fig. 5A).
xrs-2 cDNA was also introduced into xrs-6 mutants by DNA
transfection, and individual clones were analyzed for radiation
sensitivity, for DNA end binding, and for the presence of Ku70
and Ku80 protein by Western blotting (data not shown). The
level of radiation sensitivity varied between clones generated
from three independent transfection experiments, but none of
the clones had detectable Ku70 protein or DNA end-binding
FIG. 5. Examination of the effects of the xrs-2 mutation on DNA end binding. (A) DNA end-binding activity of in vitro expressed xrs-2 Ku80 protein. Ku80 cDNA
harboring the xrs-2 mutation was coexpressed with Hs Ku70 in vitro and analyzed by EMSA. Coexpression of Hs Ku70 and pcDNA3 vector, coexpression of Hs Ku70
and CH Ku80, and coexpression of Hs Ku70 and Ku80 cDNA harboring the xrs-2 mutation are shown in the three right-hand lanes. (B) DNA end-binding activity of
cells expressing the mutant xrs-2 Ku80 protein. The middle three lanes contain extracts of CHO-K1, xrs-2, and xrs-6 cells, respectively; the right-hand lane represents
extracts from xrs-6 cells expressing mutant Ku80 protein carrying the P-to-L mutation identified in xrs-2 cells. (C) Restoration of DNA end-binding activity in xrs-2 cells
expressing CH Ku80 cDNA. The two right-hand lanes contain xrs-6 and xrs-2 cells expressing wild-type CH Ku80, respectively. Autoradiographic images were scanned
on an AGFA StudioStar scanner with FotoLook32 software.
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activity (Fig. 5B shows the DNA end-binding activity). Ku80
protein was also undetectable in the majority of clones. We
also showed that wild-type CH Ku80 cDNA fully corrected
xrs-2 cells (Fig. 5C shows the DNA end-binding activity). Tak-
en together, these results support our contention from the
sequence analysis that the likely causal mutation in xrs-2 cells
is a proline-to-leucine change at position 410. This impairs the
ability of Ku80 to interact with Ku70 and thus abolishes DNA
end-binding activity. Potentially, however, some interaction re-
mains in vivo, allowing some level of complementation. How-
ever, the aberrant Ku complex appears to be unstable follow-
ing our extraction procedure.
DISCUSSION
In this and a previous study we have used two approaches to
gain insight into the function of the Ku protein (39). One
approach involves the identification of mutations in Ku80-
defective rodent cells, and the other involves a structure-func-
tion analysis of Ku80 by site-directed mutagenesis. Others have
also carried out a structural analysis of Ku80 and identified
domains required for interaction with Ku70 and for DNA
end-binding activity (5, 32, 46). Here we describe the analysis
of C-terminally truncated Ku80 proteins following coexpres-
sion with Ku70 in vitro and following expression in Ku80-
deficient xrs-6 cells. Our results, summarized in Fig. 6, show
that the C-terminal region of Ku80 is involved in an interaction
with DNA-PKcs. To facilitate the examination of this interac-
tion, we introduced human YACs encoding DNA-PKcs into
xrs-6 cells. Rodent cell-YAC fusion hybrids express levels of
DNA-PKcs similar to that found in human cells and, in the
presence of full-length Ku80 protein, have high DNA-PK ac-
tivity (36). The introduction of the 39-deleted Ku80 cDNAs
into these DNA-PKcs-overexpressing cells therefore increased
our ability to monitor the interaction between the truncated
Ku80 proteins and DNA-PKcs. The results we have obtained in
vivo are generally in agreement with our in vitro findings.
Taken together, our results show that the terminal 178 amino
acid residues are dispensable for interaction with Ku70 and for
DNA end-binding activity. In contrast, amino acid residues
from 474 to 531 are required for DNA end-binding activ-
ity. The loss of DNA end-binding activity is probably due to
reduced Ku70-Ku80 interaction as demonstrated for Hs
Ku80D510. Unfortunately, this could not be verified with the
constructs generated with CH Ku80 cDNA since our Ku80
antibodies do not cross-react with the truncated CH proteins.
The results of previous studies have defined a minimal region
of 28 amino acids from 449 to 477 required for heterodimer-
ization, although this minimal region alone has not been shown
to be sufficient for Ku70-Ku80 interaction (5, 32, 46). There-
fore, some aspects of our results differ from these previous
studies. First, although the C-terminal 178 amino acid residues
are dispensable for heterodimerization, loss of further amino
acids to residue 531 impairs interaction. Additionally, we show
that changing residue 410 from a proline to a leucine impairs
heterodimerization. Thus, in contrast to previous results, we
show that the presence of the minimal region of 28 amino acids
from 449 to 477 is not sufficient for Ku70-Ku80 interaction. A
likely explanation is that the larger protein context of our
truncated or mutated proteins may hinder protein-protein in-
teractions if the correct protein conformation is not achieved,
a feature that may not arise in the analysis of short protein
fragments. In a separate collaborative study in which muta-
tional changes have been constructed at various sites in full-
length Ku80, we have obtained further evidence that changes
at multiple sites in the N-terminal two-thirds of Ku80 can
impinge upon Ku70-Ku80 heterodimerization (39a). Further-
more, there are many sites in Ku70 at which mutations abolish
heterodimerization (24).
Previously it has been reported that DNA-PKcs has Ku-
independent DNA-binding and kinase activity, and Ku was
believed merely to stabilize DNA-PKcs/DNA binding, enhanc-
ing the kinase activity no more than eightfold (15, 47). Here,
using xrs-6 cells that overexpress DNA-PKcs, we show that Ku
can stimulate DNA-PK activity 50- to 100-fold. Our deletion
analysis shows that the C-terminal region of Ku80 is required
for interaction with DNA-PKcs and stimulation of the kinase
activity. Thus, Ku80 proteins truncated at positions 554 and
560 produce a Ku heterodimer efficient for DNA end binding
but with decreased ability to stimulate DNA-PK kinase activ-
ity. XYHs80D554 clones were not complemented for g-ray
sensitivity and were defective in coding-joint formation but
were able to recombine signal junctions. These cells have thus
acquired the phenotype of mouse SCID cells. Although we
cannot verify that the sole function of the C-terminal region of
Ku80 required for DSB rejoining is the recruitment and/or
activation of DNA-PKcs, the fact that cells lacking this region
of Ku80 but having high DNA-PKcs protein acquire the phe-
notype of cells lacking DNA-PKcs is highly supportive of this
notion. The decreased kinase activity of cells expressing Ku80
truncated proteins could arise because the C-terminal region
of Ku80 facilitates or stabilizes binding of DNA-PKcs to DNA
and/or because it activates DNA-PKcs catalytic activity, for
example by inducing a conformational change in the protein.
The presence of the C-terminal region of Ku80 markedly in-
creased the recovery of DNA-PKcs from DNA cellulose beads,
showing that Ku enhances DNA-PKcs binding to DNA. While
the recovery of DNA-PKcs protein from DNA cellulose beads
FIG. 6. Summary of results with deletion constructs analyzed. The solid box represents the minimal Ku70-Ku80 interaction domain previously identified (32); P3L
at position 410 represents the mutation in xrs-2 cells; ND, not done; S and R, sensitive and resistant to ionizing radiation, respectively; Ku70/80, heterodimerization;
DB, DNA end-binding activity; DNA-PK, DNA-PK activity.
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was similar in extracts expressing the Ku80D554 protein and
those lacking Ku (Fig. 4D, lanes XYCH80D554 and xrs6Y),
greater residual kinase activity was detected when the trun-
cated protein was present (Fig. 3B). This is consistent with the
notion that Ku enhances DNA-PKcs/DNA binding and acti-
vates DNA-PKcs catalytic activity and that the truncated pro-
teins retain some residual DNA-PKcs activation activity. How-
ever, lack of sensitivity of this analysis precludes a firm
conclusion about the relative contribution of these two poten-
tial aspects of Ku80 function. These limitations notwithstand-
ing, we conclude that the C terminus of Ku80 interacts with
DNA-PKcs, enhancing its ability to bind to DNA and to func-
tion as a DNA-dependent protein kinase.
Our results also provide evidence for Ku-independent DNA-
PKcs/DNA binding and kinase activity. Since rodent cells have
levels of DNA-PK activity only three- to fivefold above back-
ground, it was not possible previously to assess whether Ku80-
defective mutants retain low DNA-PK activity. When cell ex-
tracts that lack Ku80 protein but have high DNA-PKcs activity
(xrs-6/YAC fusion cells) are used, the level of DNA-PKcs pro-
tein recovered from DNA cellulose beads is similar to that
found in wild-type hamster cells. This may represent Ku-inde-
pendent DNA-PKcs binding to DNA but may also result from
nonspecific recovery due to the elevated DNA-PKcs activity in
these extracts. However, these same Ku-defective extracts have
low but detectable DNA-PK activity, indicative of Ku-indepen-
dent kinase activity. However, although the mutation in xrs-6
cells inactivates the Ku80 protein, we cannot exclude the pos-
sibility that there is some expression from a methylation-
silenced allele that we have shown to be present in these cells
and capable of being activated (20, 39). Furthermore, we can-
not assess whether the low activity has functional significance,
since such cells lack Ku DNA end-binding activity. Taken to-
gether, however, our results support the model proposed by
Hammarsten and Chu (15), that Ku stabilizes an interaction
between DNA-PKcs and DNA and that this interaction serves
to stimulate DNA-PK activity.
Although XCH80D560 and XYCH80D560 clones retain re-
sidual kinase activity and were partially complemented for
g-ray sensitivity, no complementation was observed with the
larger truncated protein (Hs Ku80D554), even though, in the
DNA-PKcs-overexpressing background, the cells retained some
kinase activity and indeed had DNA-PK activity greater than
that observed in CHO-K1 cells. In this context, it should be not-
ed that the in vitro kinase assay uses a p53 peptide substrate
and may not represent the constraints imposed upon the phys-
iologically relevant in vivo substrate. The ability to phosphory-
late the relevant in vivo substrate may therefore be more strong-
ly impaired than is evident from the in vitro kinase assay.
We and others have observed the presence of aberrant Ku80
proteins in some human cell extracts (references 16 and 30 and
our unpublished observations). These smaller Ku80 proteins
were similar in size to our Hs Ku80D554 protein, did not cross-
react with a Ku80 antibody specific for a C-terminal epitope,
and retained DNA end binding but had decreased kinase ac-
tivity. One particular extract had 90% smaller Ku80 protein
and barely detectable DNA-PK activity (our unpublished data).
Proteolytic degradation of Ku80 has been previously reported
(33), and, in our hands at least, the aberrant, smaller Ku80
product appears to arise during extraction. Therefore, for ex-
ample, when cells that appeared to have a smaller Ku80 pro-
tein were lysed in SDS and immediately subjected to Western
blotting, a normal-sized Ku80 protein was obtained. Our re-
sults would therefore caution that the variant Ku80 proteins
may not represent the in vivo Ku80 state and may not be
related to radiation sensitivity. Nonetheless, these results sup-
port our findings with defined Ku80 truncated proteins and
raise the possibility that such modifications of Ku have some
function in the regulation of the NHEJ process.
The C-terminal region of Ku80 is less highly conserved be-
tween species than is the rest of the Ku80 cDNA. For example,
the S. cerevisiae Ku80 cDNA is 102 amino acid residues shorter
than its human homologue and most of these nonconserved
residues are located in the C-terminal region. It is possibly
significant, therefore, that a DNA-PKcs homologue has not
been detected in yeast. In contrast, there is greater conserva-
tion between the C. elegans and mammalian sequences in this
region, raising the possibility that these cells will have a func-
tionally homologous DNA-PKcs protein. It has also been re-
ported that Ku70 and Ku80 are evolutionarily related (8).
Significantly, Ku70 lacks the C-terminal region present in
Ku80, raising the possibility that only Ku80 functions in inter-
actions with DNA-PKcs. Further work, including additional
mutational analysis of Ku80 and Ku70, is required to charac-
terize this interaction further.
A second strategy for the analysis of functionally important
residues in Ku80 is the identification of mutations in Ku80-
defective mutants. Previously, such analysis has not been in-
formative, since the changes identified resulted in large dele-
tions or truncations. Here we report the identification of a
point mutational change in the xrs-2 mutant. Additionally, we
report that the mouse GenBank sequence (U68181) has an
error at position 410 and that a proline at this position is
completely conserved between species. The proline-to-leucine
change at this site in xrs-2 impairs the ability of the Ku80
protein to interact with Ku70, possibly by affecting protein
conformation, as discussed above. Our results also show that
this mutational change does not act as a dominant-negative
mutation since the defect in xrs-2 cells can be corrected by
wild-type Ku80 cDNA.
In conclusion, we show here that the C-terminal region of
Ku80 significantly enhances the binding of DNA-PKcs to DNA
and DNA-PK activity. Significantly, xrs-6 cells expressing Ku80
constructs lacking the C-terminal 178 amino acids acquire the
phenotype of SCID cells even though they express wild-type
DNA-PKcs protein. These results suggest that an interaction
between DNA-PKcs and Ku80 is required for DSB repair and
coding joint formation and that this interaction requires the
C-terminal region of Ku80.
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